Healthcare AI Acquisition Corp.
HAIAW
NASDAQ Global Market0.01
USD
+0.00
- -
CIK
0001848861
ISIN
KYG4373K1177
CUSIP
G4373K117
Return %
Stock
S&P500
1Y
-76.07
26.53
3Y
-95.52
76.60
5Y
-95.52
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Jiande Chen
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 190 Elgin Avenue George Town Cayman Islands KY1-9008
- CIK
- 0001848861
- Similar Companies
- Business
- Healthcare AI Acquisition Corp. (HAIAW) is a blank-check company, or special purpose acquisition company (SPAC), focused on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, primarily targeting companies in the healthcare artificial intelligence sector. It offers no current products or services beyond its SPAC structure, which facilitates capital raising through an initial public offering to fund future acquisitions; its securities include Class A ordinary shares, units, and warrants traded under the HAIAW ticker on Nasdaq. The company operates principally in the United States, with potential targets spanning healthcare AI innovators developing technologies such as diagnostic tools, predictive analytics, personalized medicine platforms, and operational efficiency solutions for hospitals, pharmaceuticals, and insurers. Founded in 2023 and headquartered in New York, New York, Healthcare AI Acquisition Corp. has no disclosed subsidiaries or parent entities and remains pre-merger with no announced target as of late 2025. No major strategic changes, such as partnerships, funding rounds beyond its IPO, acquisitions, new product launches, or reorganizations, have been publicly reported in the last 1-2 years. The company targets high-growth healthcare AI firms serving clinical, administrative, and research markets across North America and potentially global regions.